Name of the Technology
Anti-Hyperglycemic Polysaccharide from a Probiotic Bacterium
The Technology
This technology is for producing an exo-polysaccharide with potential anti-diabetic activity. It is produced by simple fermentation and purification process. The molecule has been characterized in terms of sugar monomers and its ability to reduce blood glucose levels in an animal model.
USP
First anti-hyperglycemic exo-polysaccharide molecule from a probiotic GRAS(Generally Regarded As Safe) by US FDA.
Advantages
- Potential drug candidate for both type 1 and type 2 diabetes.
- Biodegradable, non-toxic and has no side effects
